Neurotoxicity Syndromes
|
group |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
34
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hallucinations, Visual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
39
|
5
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Enterocolitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
40
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Achalasia
|
disease |
|
Disease or Syndrome
|
40
|
5
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Gall Bladder Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
42
|
4
|
0.030 |
None |
1.000 |
3 |
|
1995 |
2020 |
Catalepsy
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
43
|
|
0.300 |
None |
1.000 |
2 |
|
1985 |
1985 |
Adult Gliosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
44
|
5
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2003 |
Childhood Gliosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
44
|
5
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2003 |
Morphine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Biliary calculi
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Body Substance
|
48
|
31
|
0.310 |
None |
1.000 |
2 |
|
1992 |
2008 |
Esophageal Achalasia
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
49
|
5
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Postinfarction
|
disease |
|
Disease or Syndrome
|
49
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cholesterol gallstones
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
51
|
12
|
0.040 |
None |
1.000 |
4 |
|
2016 |
2019 |
Phototoxicity
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
52
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Panic Attacks
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
59
|
3
|
0.090 |
None |
1.000 |
9 |
|
1993 |
2019 |
Pancreatitis, Alcoholic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
61
|
86
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Decrease in appetite
|
phenotype |
Digestive System Diseases; Nervous System Diseases; Mental Disorders
|
Sign or Symptom
|
62
|
7
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Sarcoma, Epithelioid
|
disease |
Neoplasms
|
Neoplastic Process
|
66
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Alcohol withdrawal syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
67
|
6
|
0.320 |
None |
0.500 |
2 |
|
1999 |
2000 |
Gastrointestinal symptom
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
69
|
7
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Hunger
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
70
|
12
|
0.050 |
None |
0.800 |
5 |
|
2017 |
2019 |
Nonnuclear polymorphic congenital cataract
|
disease |
|
Congenital Abnormality
|
71
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Liver Dysfunction
|
phenotype |
Digestive System Diseases
|
Finding
|
73
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neurobehavioral Manifestations
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Sign or Symptom
|
77
|
3
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Periosteal Disorder
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
80
|
|
0.020 |
None |
< 0.001 |
2 |
|
2020 |
2020 |